Insiders Biohaven Pharmaceutical Holding Company Ltd.

Equities

Real-time Estimate Cboe BZX Other stock markets 02:15:47 2024-04-29 pm EDT			5-day change	1st Jan Change
39.65 ^USD	+1.74%		-0.05%	-73.64%

Apr. 25	Biohaven Insider Bought Shares Worth $999,169, According to a Recent SEC Filing	MT
Apr. 23	Biohaven Shares Rise After Closing of Public Offering, Disclosure of Stock Purchase by CEO	MT

Biohaven Insider Bought Shares Worth $999,169, According to a Recent SEC Filing	Apr. 25	MT
Biohaven Insider Bought Shares Worth $7,999,961, According to a Recent SEC Filing	Apr. 23	MT
Biohaven Insider Bought Shares Worth $4,999,991, According to a Recent SEC Filing	Apr. 23	MT
Biohaven Insider Sold Shares Worth $459,663, According to a Recent SEC Filing	Jan. 02	MT
Biohaven Insider Bought Shares Worth $9,999,990, According to a Recent SEC Filing	23-10-11	MT
Biohaven Insider Bought Shares Worth $9,999,990, According to a Recent SEC Filing	23-10-10	MT
Biohaven Insider Bought Shares Worth $499,994, According to a Recent SEC Filing	23-10-06	MT
Biohaven Insider Bought Shares Worth $402,094, According to a Recent SEC Filing	23-10-06	MT
Biohaven Director Buys 50,000 Shares for $922,180	23-08-31	MT
Insider Buy: Biohaven	23-08-07	MT
Mike Heffernan appointed Chairman of NMD Pharma's Board of Directors	23-01-04	AQ
Insider Buy: Biohaven	22-11-01	MT
Insider Buy: Biohaven	22-10-31	MT
Insider Buy: Biohaven	22-10-27	MT
Insider Buy: Biohaven	22-10-27	MT
Insider Buy: Biohaven	22-10-27	MT
Insider Buy: Biohaven	22-10-27	MT
Biohaven Pharmaceutical Holding Company Announces Management Changes	22-10-03	CI
Insider Buy: Biohaven Pharmaceutical Holding Co	22-08-23	MT
Biohaven Pharmaceutical Holding Company Ltd. Appoints Irina Antonijevic, M.D., Ph.D., as A Director, Effective May 1, 2022	22-04-15	CI

No results for this search